A pan-cancer study analyzing Tumor-infiltrated T cells at a single-cell resolution identified patients with low Tex cells and high Trm cells infiltrations had longer survival and higher response rates to PD-1 inhibitors (51). This evidence concerns the gene PDCD1 and cancer.